2026
-
01
-
26
點擊次數:
太美智研醫藥研發(上海)有限公司(簡稱“太美智研醫藥”),總部位于上海,是AI驅動的醫藥研發解決方案提供商。依托深厚臨床研究積淀,公司深度融合A 技術與創新模式,為全球藥械企業及科研機構提供國際品質的一站式臨床研究解決方案,以標準化運營與全流程賦能,構建高質合規、高效透明的研發體系,加速創新轉化。公司具備臨床早期至上市后全鏈條服務能力,業務覆蓋法規注冊事務、醫學事務、項目運營管理、統計分析與編程、數據管理、獨立評估、藥物警戒、患者招募及真實世界洞察。迄今已服務600余家藥械企業,開展1600余項臨床研究,覆蓋腫瘤、心血管、自免、內分泌、腎臟等多個治療領域。憑借全流程專業實力,助力多項關鍵臨床研究大幅縮短研發周期,推動新藥早日獲批上市。 公眾號二維碼: 公司網站:www.taimei.comTaimei CRO is an Al-driven provider of pharmaceutical R&Dsolutions. LeveragingAl as the core driver, we deeply integrateclinical research expertise,Al technol-ogy, and innovative models to offer the industry a moreefficient, transparent, and high-quality intelligent solution. Thiscomprehensive delivery includes:Clinical Operations, Data Science, Medical Science, RegulatoryAffairs, Pharmacovigilance, Patient Recruitment andManagement Platforms, IndependentAssessment & Real-World Insights.We have supported over 600 pharmaceutical and medicaldevice enterprises, delivered more than 1,600 clinical studies,and spanned major therapeutic areassuch as oncology, cardiology, autoimmune, endocrinology,and nephrology. Our end-to-end expertise has drasticallyshortened R&D timelines for critical trials,accelerating the approval and launch of new drugs.